Open AccessRivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
Author(s) -
Michael R. Lassen,
Walter Ageno,
Lars C. Borris,
Jay R. Lieberman,
Nadia Rosencher,
Tiemo J. Bandel,
Frank Misselwitz,
Alexander G.G. Turpie
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa076016
Subject(s) - medicine , rivaroxaban , arthroplasty , total knee arthroplasty , enoxaparin sodium , surgery , thrombosis , warfarin , low molecular weight heparin , atrial fibrillation
We investigated the efficacy of rivaroxaban, an orally active direct factor Xa inhibitor, in preventing venous thrombosis after total knee arthroplasty.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom